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Mycobacterium tuberculosis direct test compared with 
smear and culture for the diagnosis of pulmonary 
tuberculosis 
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and Giuseppina De Sio' 
'Department of Clinical Microbiology and *Pulmonary Division, General Hospital 'Umberto 
1'-Torrette', Ancona, and 3Division of Pulmonary Medicine, General Hospital 'A. Murri', 
Jesi (AN), Italy 
Objective: To evaluate the clinical efficacy of the Gen-Probe amplified Mycobacterium tuberculosis direct test (AMTD), 
a recently developed amplification test for the detection of M. tuberculosis complex directly from clinical specimens, for 
the diagnosis of pulmonary tuberculosis and its suitability for use in  a routine microbiology laboratory. 
Methods: Sequential respiratory specimens were tested with AMTD and results were compared with those of acid-fast 
stain and culture. Performance of AMTD was tested over a 13-month period, using 278 respiratory specimens, from 219 
patients, submitted to  the microbiology laboratory of our hospital. AMTD's sensitivity, specificity and positive and 
negative predictive values were determined, with the combination of culture and clinical diagnosis being taken as the 
standard. 
Results: Thirty-three specimens were collected from 23 patients with a conclusive diagnosis of pulmonary tuberculosis. 
Of these specimens, 13 were smear positive, 22 culture positive and 30 AMTD positive. AMTD was more sensitive in 
detecting pulmonary tuberculosis in patients partially treated but with undiagnosed disease (100%). and in  smear- 
positive disease (100%). The overall sensitivities, specificities and positive and negative predictive values were: 39.4%. 
loo%, 100%. and 92.4% for staining; 66.7%. loo%, 100% and 95.7% for culture; and 90.9%, 100%, loo%, and 98.8% for 
AMTD. 
Conclusions: AMTD is a rapid, reliable and accurate test for the detection of M. tuberculosis complex in respiratory 
specimens. Repeat testing of those samples whose results fall between 30 000 and 300 000 relative light units, increases 
test specificity by preventing the majority of false positives. 
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INTRODUCTION 
Over the past two decades, available therapies for the 
management of pulmonary tuberculosis have improved 
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considerably. The introduction of new regimens (short- 
course and intermittent chemotherapy) has proved 
effective in reducing the load and cost of drugs [l], 
ensuring patient compliance [2] and lowering failure/ 
relapse rates [ 3 ] .  In addition, direct observation of 
therapy has been shown to reduce non-compliance 
rates [4]. Despite this, tuberculosis is on  the increase 
throughout the world [S] and remains one of the few 
infectious diseases whose diagnosis often relies on 
clinical suspicion. 
The majority of routine clinical laboratories 
still depend on acid-fast bacilli (AFB) smear and 
culture, whose limitations are well known. Microscopy, 
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although quick and easy, has poor sensitivity [6,7], 
while culture on solid media is more specific and 
sensitive, but can take several weeks to be carried out. 
More recently, the use of liquid media in conjunction 
with nucleic acid probes (Accuprobe, Gen-Probe Inc., 
San Diego, USA) has considerably shortened detection 
time [6,7], but even these procedures require a 
minimum of 2 weeks before a definitive laboratory 
diagnosis of tuberculosis can be made. Recent studies 
have focused on the rapid, direct detection of Myco- 
bacterium tuberculosis for initial diagnosis of pulmonary 
tuberculosis [8,9]. Different assays which amplify either 
DNA or R N A  have been used for this purpose. Some 
commercially available kits, employing standardized 
nucleic acid-based amplification techniques, can yield 
reliable results within 5-7 h of sample processing 
(10-131. The Gen-Probe amplified M. tuberculosis direct 
test (AMTD) (Gen-Probe Inc., San Diego, USA) is a 
diagnostic test based on the isothermal amplification of 
rRNA via DNA intermediates, with detection of the 
amplified product by an acridinium-ester-labeled DNA 
probe. The aim of the present study was to evaluate 
the utility of this test for the diagnosis of pulmonary 
tuberculosis. 
MATERIALS AND METHODS 
Specimen collection and processing 
Two hundred and seventy-eight sequential respiratory 
tract specimens from 219 patients, including 
expectorated or induced sputa, gastric aspirates and 
bronchoscopy specimens (bronchial aspirates and 
bronchoalveolar lavages), collected by the Clinical 
Microbiology Department of the Umberto I"-Torrette 
Hospital between October 1995 and November 1996, 
were included in the study. AU specimens were 
liquefied with N-acetyl-L-cysteine and decon- 
taminated with NaOH (final concentration 1.5%). 
After decontamination, an equal volume of phosphate 
buffered saline (PBS) of pH 6.8 was added, and the 
specimens were centrifuged at 3500g for 20 min at 4°C. 
The sediment was resuspended in 2 mL of PBS and 
neutralized with 1 M HC1. Part of the sediment 6-om 
each specimen was inoculated on the culture medium 
and used for acid-fast staining, while the remainder was 
stored at  4°C for no more than 48-72 h until the 
amplification assay was performed. 
Culture 
The processed sediment (0.5 mL) was cultivated by a 
radiometric Bactec technique (Becton-Dickinson Diag- 
nostic Instrument Systems, USA) and by h4B-Check 
AFB culture bottles (Becton Dickinson Microbiology 
Systems, USA) [6,7]. In addition, 0.2 mL of the 
sediment was inoculated on Lowenstein-Jensen (LJ) 
medium. The LJ tubes and MB-Check AFB bottles 
were incubated at 35-37OC for 8 weeks and inspected 
for growth twice a week €or the first 4 weeks and 
weekly thereafter. The radiometric growth index of 
cultures grown in the Bactec instrument was auto- 
matically recorded twice a week for 6 weeks. A growth 
index of > 10 was considered to be positive, and smears 
were made to confirm the presence of acid-fast bacilli 
{AFB) . 
Microscopy 
Smears were stained by the Ziehl-Neelsen method and 
examined under the oil-immersion objective lens of 
the microscope (x1000). 
Identification of mycobacteria 
Isolates were identified by specific DNA probes 
(Accuprobe Gen-Probe Inc., San Diego, USA) and by 
standard procedures [14]. 
Gen-Probe AMTD procedure 
The amplification assay was tun in three separate 
areas, set up in two different rooms to avoid the 
possibility of contamination. The Gen-Probe Ah4TD 
assay (Gen-Probe Inc., San Diego, USA) was per- 
formed in accordance with instructions supplied by 
the manufacturer. Briefly, a 50-pL aliquot of sediment 
was added to a tube containing glass beads and sample 
buffer and sonicated for 15 min in a water-bath soni- 
cator at room temperature. A 50-pL aliquot of lysate 
was added to a tube containing 25 pL of amplification 
reagent and 200 pL of oil. The tube was incubated at  
95°C for 15 min and then cooled to 42°C for 5 min. 
An enzyme reagent mix was added, and the mixture 
was incubated at  42°C for 2 h. Termination reagent 
was added, and the reaction mixture was further 
incubated at  42°C for 10 min. For detection, a specific 
labeled hybridization probe was added to the tube and 
incubated at 60°C for 15 min, followed by addition of 
a selection reagent and incubation at  60°C for a further 
10 min. Samples were read in a Leader 50 luminometer 
(Gen-Probe, Inc., San Diego, USA), and a cut-off value 
of 30 000 relative light units (RLU), corresponding to 
approximately 40 mycobacteria, was used for positive 
specimens [15]. Each run included positive and negative 
amplification controls as well as poiitive and negative 
hybridization controls. Moreover, two smear-positive 
sediment samples of clinical origin, previously collected 
and stored at  -8OoC, were also included as controls in 
each run. 
Patient clinical evaluation 
Clinical assessment included the patient's medical history, 
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signs, symptoms, chest X-ray, microbiological results, 
and follow-up observations, as well as the results 
obtained from additional specimens collected prior 
to patient admission into hospital or during the follow- 
up. All patient records were reviewed by a tuber- 
culosis expert and each was classified according to 
the American Thoracic Society (ATS) tuberculosis 
classification 1161. Thus, a combination of culture and 
clinical diagnosis was set as the standard. Following this 
analysis, AMTD discrepant results were reclassified as 
appropriate. 
Clinical and microbiological data 
Two hundred and seventy-eight specimens from 21 9 
patients were collected during the study period. The 
specimens included 142 bronchial aspirates, 110 sputa, 
20 gastric aspirates and six bronchoalveolar lavages. All 
patients except two were white, and the majority of 
them (151) were male. About 10% of the patients had 
identified risk factors for tuberculosis, such as HIV- 
positive status, intravenous drug use or homelessness. 
Analytic performance of Gen-Probe AMTD assay and RLU 
values 
Positive and negative results could be clearly distin- 
guished by the magnitude of the RLU value. The 
majority of smear-positive, culture-positive samples 
for M .  tuberculosis exceeded 1 700 000 RLU. O f  the 
specimens collected from patients strongly suspected 
of having tuberculosis (smear negative, culture positive 
or smear and culture negative), 71%) exhibited values 
with a greater magnitude, whereas 29% showed 
values < 1 000 000 RLU (range 94 396-753 393 RLU). 
Samples with negative results had values far below the 
cut-off of 30 000 RLU, with 89.9% being <10 000 
RLU. All negative values obtained upon AMTD repeat 
assay fell below 10 000 RLU. 
Comparison of smear, culture and AMTD results 
From the 278 respiratory Specimens, four Bactec cultures 
grew nontuberculous mycobacteria, including M.  
auiuvn (two isolates), M.  prdonue  (one isolate) and M.  
t w u e  (one isolate). In all these cases, AMTD remained 
negative. 
From the clinical speciniens tested, 20 were AMTD 
and culture positive and 221 were negative by both 
techniques. In total, there were 37 discrepant results: 31 
were AMTD positive, but negative by culture, and for 
six specimens, all smear negative, the opposite was true. 
0 1 1  the basis of these data, the sensitivity, specificity, 
positive predictive value (PPV) and negative predictive 
value (NPV) of AMTD were 90.9%, 85.7%, 58.896, 
and 98.6%, respectively. 
Of  the 31 results suspected to be false positive, 
10 were from eight patients with pulmonary tuber- 
culosis who had been partially treated, and still had 
undiagnosed disease (ATS class 5). In these cases, 
M.  tubevculosis grew from samples collected prior to 
admission to our hospital and antibiotic therapy, or 
from additional sputum specimens. The remaining 21 
specimens were from patients lacking any sign of active 
pulmonary tuberculosis. About 50% of these specimens 
showed RLU values of < 100 000, ranging from 35 910 
to 317 288 RLU (mean value 152 069 RLU). Upon 
repeat AMTD assay, all 21 samples were negative. This 
phenomenon has previously been reported in the 
literature by Pfjiffer et a1 [17], who also suggested that 
repeat testing of specimens yielding weakly positive 
values helps to prevent the majority of false-positive 
results. According to this procedure, we decided to 
consider for final evaluation the results obtained upon 
repeat AMTD assay. 
O f  the six specimens from five patients suspected 
as being false negative, four grew non-tuberculous 
mycobacteria, so only two were considered to be true 
false negatives. A combination of three culture methods 
(Bactec 12B, MB-Check AFB bottles and LJ medium) 
was used in the coniparison with AMTD. About 
60% of samples grew on all three media: Bactec 12B 
performed the best, followed by MB-Check AFB 
and LJ medium. After the resolution of discrepancies, 
the sensitivity, specificity, PPV and NPV of AMTD 
increased to 90.9%, loo%, 10096, and 98.8%, respec- 
tively (Table 1). Distinguishing between smear-positive 
( n  = 13) and smear-negative ( n  = 265) samples, uncor- 
rected values for AMTD sensitivity were 100% and 
86.9%, respectively. Specificities were 100% and 91.3%, 
respectively. For smear-negative samples, specificity 
increased to 100% after resolution of discrepant results. 
The performances of smear, culture and AMTD 
for specimens collected from patients who entered the 
study with active tuberculosis (ATS class 3) or were 
strongly suspected of having tuberculosis (ATS class 5) 
Table 1 Sensitivity, specificity and predctivc values of 
various methods” 
Predictive value (96) 
Mcthod Sensitivity (‘%) Spccificity (%) I’ositivc Negative 
Smear 39.4 100 100 92.4 
Culture 66.7 100 1 0 0  95.7 
AMTD 90.9 1OU 100 98.8 
’The combination of culture results and clinical diagnosis xva~ taken 
as the standard. 
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Table 2 Comparison of smear, culture and Ah4TD results versus initial ATS classification 
Smear Culture AMTD Specimens 
(i1=278) 0 , 1 , 2  3 4 5 0 , 1 , 2  3 4 5 0 , 1 , 2  3 4 5 
0 1 3 0 0  42 22 0 0 0' 20 0 10 
Negative 235 9 10 11 23 1 0 10 11 235' 2 10 1 
Positive 
(214)' 
"These specimens grew MOTT. 'Before discrepant results repeat. 'After discrepant results repeat. 
Table 3 AMTD compared with the standard (culture and 
clinical diagnosis) 
No. of patients with 
conclusive diagnosis of tuberculosis 
AMTD 





"Data in the table were calculated after resolution of discrepant 
results. 
Sensitivity, 91.3%; specificity, 100%; PPV, 100%; NPV, 98.9%. 
are compared in Table 2. Twenty-two samples from 15 
class 3 patients were obtained. Smear was positive in 13 
samples, culture in 22 and AMTD in 20. There were 
11 specimens from eight patients with suspected tuber- 
culosis (ATS class 5 )  who ultimately were confirmed as 
having active disease. Surprisingly, AMTD was positive 
in 10 specimens, while smear and culture were both 
negative in all. When all samples were evaluated for 
each individual patient, taking the combination of 
culture and clinical diagnosis as the standard, AMTD 
performed very well, detecting 21 of 23 patients 
(91.3%) with active tuberculosis (Table 3). 
DISCUSSION 
This study evaluated the clinical utility of a commer- 
cially available amplification assay (Gen-Probe AMTD) 
for the rapid diagnosis of pulmonary tuberculosis. In 
our experience, 100% of patients with both AMTD- 
and smear-positive results had pulmonary tuberculosis. 
Similarly, when both tests were negative, tuberculosis 
could be excluded with 98.9% certainty. Nevertheless, 
amplification methods for smear-positive sputum speci- 
mens are still regarded as unnecessary. Recent studies 
have shown that even when M.  avium is prevalent in 
the clinical setting owing to a large number of HIV- 
infected subjects, the presence of AFB in the sputum 
smear is almost entirely due to M.  tuberculosis [18]. 
In this study, the overall sensitivity of AMTD 
equalled and sometimes exceeded that of culture. 
Unlike culture, however, AMTD results were avail- 
able within a few hours. When amplification and 
smear results were in disagreement, AMTD diagnostic 
accuracy proved superlative. In smear-negative samples, 
AMTD sensitivity and PPV value were 86.9% and 
1 00%, respectively. In particular, of' the 11 smear- and 
culture-negative samples, obtained from eight patients 
strongly suspected of having tuberculosis (ATS class 5), 
10 were AMTD positive. As thesc: patients had been 
partially treated based exclusively o n  clinical suspicion, 
only AMTD-positive results, due to the shedding of 
non-culturable mycobacteria, were able to establish the 
correct diagnosis. Pulmonary tuberculosis could be 
confirmed in all the patients who grew M.  tuberculosis 
from samples obtained prior to :idmission into our 
hospital, when they were still untreated, or from 
follow-up sputum specimens. 
False negatives may be almost entirely due to the 
low number of mycobacteria unequally distributed in 
the test specimen, to the presence of amplification 
inhibitors or to low levels of rRNA amplification 
targets depending upon poor mycobacterial viability. 
There were 31 specimens with pos:,tive AMTD results, 
but with negative cultures. Of  these, 10 turned out to 
be positive (Table 2), while the other 21 exhibited 
RLU values slightly above the cut-off and were true 
negatives upon retesting. In our opinion, all the samples 
showing positive results within a 10-fold limit of 
the proposed cut-off value (30 000 RLU) should be 
retested. This procedure did not increase the false- 
negative rate, because weakly positive results obtained 
from ATS class 3 patients were all confirmed as positive 
upon retesting. Such an empirical laboratory practice 
permitted us to avoid all the false positive results. These 
phenomena remain to be explaine'd. 
AMTD sensitivity, specificity, PPV and NPV were 
90.9%, loo%, 100% and 98.8%, respectively. Our find- 
ings are in agreement with the 1iter.ature (sensitivity and 
specificity ranging from 91% to 98.4% and from 96.9% 
to loo%, respectively) [10,19-231. The specificity of 
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100% is slightly higher than what we have observed 
previously (98.9%). This can be attributed to our 
experience-guided practice of testing all the samples 
whose RLU values fell within the ‘gray zone’ (between 
>30 000 and -300 000 RLU). 
In conclusion, AMTD is demonstrated to be a 
useful tool for the diagnosis of pulmonary tuberculosis 
and suitable for a clinical microbiology laboratory’s 
workflow. However, amplification techniques can at 
present only complement conventional microbiological 
procedures, not replace them. 
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